Pack of 10 vials6 in stockSave 22%CJC-1295 + Ipamorelin 5 mg + 5 mg
Classical GHRH + ghrelin mimetic stack
CJC-1295 and Ipamorelin research stack, Australian-shipped. Lab-verified to ≥99% purity.
Research Use Only. This compound is sold strictly for in-vitro research and laboratory purposes and is not intended for human consumption or therapeutic use. By purchasing you confirm you are a qualified researcher and agree to our full disclaimer.
Only 6 packs left
Combined research vial pairing the CJC-1295 GHRH analogue with the selective ghrelin-mimetic Ipamorelin. The most-studied dual-mechanism GH secretagogue stack in peptide research.
CJC-1295 and Ipamorelin are a long-standing pair in growth-hormone secretagogue research. CJC-1295 is a 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective ghrelin receptor agonist (a 'GHS' or growth-hormone secretagogue). The two compounds act on different receptors but converge on the somatotrophs of the anterior pituitary, where they amplify pulsatile growth-hormone release in pre-clinical models.
Quantum Labs supplies the pair as a pre-portioned research stack — two lyophilised vials shipped together, each HPLC-verified to ≥99% purity. Australian-shipped from local stock; supplied for laboratory research use only.
Mechanism
CJC-1295 supports basal GHRH receptor signalling while Ipamorelin drives selective ghrelin-receptor pulses. Research suggests synergistic, naturalistic GH release patterns in study subjects.
HPLC verified against a ≥99% purity specification. Independently tested by accredited third-party laboratories.
CJC-1295: DAC vs no-DAC
CJC-1295 exists in two research forms: with Drug Affinity Complex (DAC) and without. The DAC variant binds albumin in plasma, extending the half-life from minutes to days. Research designs targeting acute pulsatile GH release typically use the no-DAC form (modified GRF 1-29); studies modelling sustained GH elevation use the DAC variant. Our supply is the no-DAC research-grade form unless otherwise specified.
CJC-1295 + Ipamorelin — frequently asked questions
What is the CJC-1295 + Ipamorelin stack?
It is a research pairing of two growth-hormone secretagogues: CJC-1295 (a GHRH analogue) and Ipamorelin (a selective ghrelin receptor agonist). The two compounds act on different receptors but converge on stimulating pulsatile growth-hormone release in pre-clinical models.
How does CJC-1295 differ from Ipamorelin?
CJC-1295 mimics growth-hormone-releasing hormone (GHRH), binding the GHRH receptor on pituitary somatotrophs. Ipamorelin mimics ghrelin, binding the growth-hormone secretagogue receptor (GHSR-1a). The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone.
Is CJC-1295 + Ipamorelin legal in Australia?
Both compounds are restricted for human therapeutic supply in Australia and remain available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies the stack for research use only.
What does selective mean for Ipamorelin?
Ipamorelin is described as a selective ghrelin agonist because it activates the GH-release pathway with minimal effect on cortisol, prolactin, or aldosterone — distinguishing it from earlier-generation GHS molecules. This selectivity has made it a preferred research tool for isolating GH-specific effects.
What is the typical CJC-1295 + Ipamorelin research dosage?
Published research protocols have used wide dose ranges depending on the model and species. Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Are CJC-1295 and Ipamorelin used together?
Yes — combined-administration research is common precisely because the two compounds act on independent receptors and produce a synergistic GH-release response. The combination is a standard tool in growth-hormone secretagogue research.
Guides related to CJC-1295 + Ipamorelin
Researchers also explore
FeaturedPack of 10 vialsSave 16%HGH
Lyophilised powder10 IU · 4 strengths
Recombinant human growth hormone
In 2 stacks
Pack of 10 vialsSave 18%Tesamorelin
Lyophilised powder10 mg · 3 strengths
Stabilised GHRH analogue
In 1 stack
FeaturedPack of 10 vialsSave 22%Melanotan II
Lyophilised powder10 mg
α-MSH analogue research peptide